What is Sulfameth trimethoprim 800 mg used for?
This medication is a combination of two antibiotics: sulfamethoxazole and trimethoprim. It is used to treat a wide variety of bacterial infections (such as middle ear, urine, respiratory, and intestinal infections). It is also used to prevent and treat a certain type of pneumonia (pneumocystis-type).
What type of infections does sulfamethoxazole treat?
What is h43 pill?
Drug: Sulfamethoxazole and Trimethoprim.
How long does it take for trimethoprim to kick in?
How long will it take to work? Symptoms should start to ease within 24 hours and should have gone after 3 days of treatment. If you still have symptoms after this time or they become worse then you need to see a doctor face to face.
Is sulfamethoxazole used to treat STD?
Official Answer. Sulfamethoxazole/TPM would be ineffective against gonorrhoea and chlamydia. Chlamydia is caused by the bacteria Chlamydia trachomatis. Chlamydia can be treated with a variety of antibiotics, including azithromycin, tetracyclines, quinolones, and erythromycin.
How long does it take for sulfamethoxazole to start working?
Bactrim (sulfamethoxazole / trimethoprim) is absorbed by the body and begins to kill bacteria within 1 to 4 hours after taking your dose. For more common problems like urinary tract infections and ear infections, most people will start to feel relief after a few days.
Is sulfamethoxazole used for STD?
Sulfamethoxazole/TPM would be ineffective against gonorrhoea and chlamydia. Chlamydia is caused by the bacteria Chlamydia trachomatis. Chlamydia can be treated with a variety of antibiotics, including azithromycin, tetracyclines, quinolones, and erythromycin. Gonorrhea is caused by the bacteria Neisseria gonorrhoeae.
What is VP 120 pill used for?
VP 120 (Sulfamethoxazole and Trimethoprim 800 mg / 160 mg) Sulfamethoxazole/trimethoprim is used in the treatment of bacterial skin infection; bacterial infection; bronchitis; upper respiratory tract infection; traveler’s diarrhea and belongs to the drug class sulfonamides.
